By screening a library of compounds for the ability to induce mitotic defects, researchers identified AZ0108 as a potent ARTD17 inhibitor, showing antitumor effects in vivo and inducing cell death in breast cancer cells in vitro [144,157]. This evidence concerns the gene PARP6 and breast carcinoma.